Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Minerva Medica|September 21, 2020
Tagraxofusp and anti-CD123 in blastic plasmacytoid dendritic cell neoplasm: a new hopeDelia Cangini, Paolo Silimbani, Alessandro Cafaro, et al.
Plos One|December 17, 2024
Body weight and body surface area of adult patients with selected cancers: An Italian multicenter studyValentina Danesi, Alice Andalò, Martina Cavallucci, et al.
Frontiers in Oncology|February 26, 2026
A rare case report of relapsed/refractory primary cutaneous diffuse large B-cell lymphoma, leg type, treated with Epcoritamab: results obtained and lesson learnedAlessandro Cafaro, Francesco Malaspina, Pietro Rossi, et al.
Frontiers in Pharmacology|December 21, 2020
Hydroxychloroquine as Prophylaxis for COVID-19: A ReviewManuela Monti, Bernadette Vertogen, Carla Masini, et al.
The Oncologist|March 25, 2021
Prospective Observational Study Comparing Calcium and Sodium Levofolinate in Combination with 5-Fluorouracil in the FOLFIRI RegimenAlessandro Passardi, Manlio Monti, Caterina Donati, et al.
Oncotarget|April 28, 2016
Multicentric survey on dose reduction/interruption of cancer drug therapy in 12.472 patients: indicators of suspected adverse reactionsAndrea Casadei Gardini, Elena Tenti, Carla Masini, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 24, 2016
Robotic i.v. medication compounding: Recommendations from the international community of APOTECAchemo usersAngela W Yaniv, Adam Orsborn, Joseph J Bonkowski, et al.
BMJ Open|January 12, 2022
Use of the ONCO-TreC electronic diary compared with a standard paper diary to improve adherence to oral cancer therapy in patients with solid and haematological tumours: protocol for a randomised controlled trialAlessandro Passardi, Patrizia Serra, Orazio Caffo, et al.
Trials|August 2, 2020
PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trialOriana Nanni, Pierluigi Viale, Bernadette Vertogen, et al.
Clinical Drug Investigation|July 20, 2024
The Early Access and the Potential Cost Savings by the Compassionate Use of Onco-haematological Drugs: Results from the Italian Study Compass-OIrene Dell'Anno, Leonardo Dondi, Immacolata Esposito, et al.
Pageof 4